Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin Dose Ranging for Prevention of Travelers' Diarrhea
NCT00098384Phase 2Completed
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifaximin in traveler's diarrhea (TD). Started Jun 2003; status: completed.
02
Drugs
rifaximin
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT00098384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098384.